Biotech · Public company · Durham, NC, US
Humacyte, Inc.
Ticker HUMA · SEC CIK 0001818382
Track this companyFree. Adds Humacyte, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials61 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline9
- Acellular Tissue Engineered Vessel (ATEV)Phase 3 · End Stage Renal Disease (ESRD)ClinicalTrials.gov · fetched Nov 12, 2026
- Acellular Tissue Engineered Vessel (ATEV)Phase 3 · TraumaClinicalTrials.gov · fetched Nov 12, 2026
- Arteriovenous fistula (AVF)Phase 3 · Renal FailureClinicalTrials.gov · fetched Nov 12, 2026
- AVFPhase 3 · End Stage Renal Disease (ESRD)ClinicalTrials.gov · fetched Nov 12, 2026
- ePTFE graftPhase 3 · Renal FailureClinicalTrials.gov · fetched Nov 12, 2026
- HemodialysisPhase 3 · Renal FailureClinicalTrials.gov · fetched Nov 12, 2026
- Human Acellular Vessel (HAV)Phase 3 · Renal FailureClinicalTrials.gov · fetched Nov 12, 2026
- Human Acellular Vessel (HAV)Phase 2 · Peripheral Artery DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- HAVGPhase 1 · End-stage Renal DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring HemodialysisPHASE3 · ACTIVE_NOT_RECRUITING · started Sep 7, 2023ClinicalTrials.gov NCT05908084 · fetched Nov 12, 2026
- Humacyte Acellular Tissue Engineered Vessel (ATEV) in Patients With Vascular TraumaPHASE2_PHASE3 · COMPLETED · started Sep 1, 2018ClinicalTrials.gov NCT03005418 · fetched Nov 12, 2026
- Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for HemodialysisPHASE3 · COMPLETED · started Sep 29, 2017ClinicalTrials.gov NCT03183245 · fetched Nov 12, 2026
- Humacyte's HAV for Femoro-Popliteal Bypass in Patients With PADPHASE2 · COMPLETED · started Dec 20, 2016ClinicalTrials.gov NCT02887859 · fetched Nov 12, 2026
- Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for HemodialysisPHASE3 · COMPLETED · started May 24, 2016ClinicalTrials.gov NCT02644941 · fetched Nov 12, 2026
- Safety and Efficacy of a Vascular Prosthesis for Hemodialysis Access in Patients With End-Stage Renal DiseasePHASE1 · COMPLETED · started May 23, 2013ClinicalTrials.gov NCT01840956 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 28, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 12, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Aug 12, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jul 31, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 11, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 10, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 9, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 5, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 13, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 8, 2026 · fetched Nov 12, 2026